Cell Receptor SA

Swiss Biotech Association

Not a member

Cell Receptor Inc. has IP for improving results in oncological treatment by targeting upstream steps of growth signaling, not noticed in oncology yet. A well-tolerated affordable treatment of low toxicity! It will prevent metastasis in most cancers.

http://www.cellreceptor.ch

Location

Route de Chêne 30A, 1208 Geneva, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2017
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

InkVivo Technologies AG

InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricated novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).
Lugano

Member

Kisco Sarl

Kisco is offering procurement and outsourcing services, giving you precious time back, allowing your company to focus on the science and development of your products, when you need it most with a keen focus on budget and innovative therapies.
2000 Neuchâtel

Member

Qiáo Advisors GmbH

We offer bespoke consulting to biotechs and investors, increasing the value of innovations by accelerating and broadening patient access. 桥 (qiáo) means “bridge” in Mandarin. Our vision is to enable a seamless healthcare system for the benefit of patients, by building bridges between stakeholders.
4153 Reinach

Member